PEROXIDASE-CATALYSED COVALENT BINDING OF THE ANTITUMOR DRUG 2N-METHYL-9-HYDROXY-ELLIPTICINE TO PROTEINS

被引:22
作者
AUCLAIR, C [1 ]
MEUNIER, B [1 ]
PAOLETTI, C [1 ]
机构
[1] LAB CHIM COORDINAT,F-31400 TOULOUSE,FRANCE
关键词
D O I
10.1016/0006-2952(83)90170-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:3883 / 3886
页数:4
相关论文
共 4 条
[1]   BIOACTIVATION OF THE ANTI-TUMOR DRUGS 9-HYDROXYELLIPTICINE AND DERIVATIVES BY A PEROXIDASE HYDROGEN-PEROXIDE SYSTEM [J].
AUCLAIR, C ;
PAOLETTI, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (03) :289-295
[2]   PRELIMINARY TRIAL OF 9-HYDROXY-2-METHYL ELLIPTICINIUM (NSC 264-137) IN ADVANCED HUMAN CANCERS [J].
JURET, P ;
TANGUY, A ;
GIRARD, A ;
LETALAER, JY ;
ABBATUCCI, JS ;
DATXUONG, N ;
LEPECQ, JB ;
PAOLETTI, C .
EUROPEAN JOURNAL OF CANCER, 1978, 14 (02) :205-206
[3]  
LEPECQ JB, 1975, CR ACAD SCI D NAT, V281, P1365
[4]   UNEXPECTED REGIOSPECIFIC ALKYLATION OF THE ANTI-TUMOR AGENT N-2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE WITH N-DONORS, O-DONORS OR S-DONORS [J].
MEUNIER, G ;
MEUNIER, B ;
AUCLAIR, C ;
BERNADOU, J ;
PAOLETTI, C .
TETRAHEDRON LETTERS, 1983, 24 (04) :365-368